1 nt prep; 42.5 % GrB vs 24 % GrA had
adequate prep.
2 inhibitory genes, Fgf inhibitory genes,
and prep, which encodes a TALE-family homeodomain protein, a
3 onents in preparative fractionations such
as prep TREF (which normally uses xylene), by using TCB as
4 Mechanical
bowel prep without oral antibiotics was administered to 49.6%
5 Patients receiving
bowel prep with oral antibiotics were also less likely to have
6 ntrol, and oral antibiotics given when
bowel prep used (SCIP-1 was not significant).
7 eum was disrupted using an
electrocardiogram prep pad prior to patch application.
8 66.5 % Gr B vs 38 % Gr A had
excellent prep; 42.5 % GrB vs 24 % GrA had adequate prep.
9 on prep (SFP)) and gravity-driven
filtration prep (GFP)) and pre-dispensed lyophilized reagents.
10 ple preparation workflows (simple
filtration prep (SFP)) and gravity-driven filtration prep (GFP)) an
11 We developed the
GC prep method as a solution to this problem.
12 The PREP suite is freely available at
http://
prep.unl.edu/.
13 ices (LI) between biopsies taken after
Klean-
prep and those taken after Picolax preparation, for both
14 depth requirements, fast and simple
library prep and high resolution splice site detection.
15 atients, whereas 36.4% received a
mechanical prep and oral antibiotics.
16 Of 8442 patients, 2296 (27.2%) had
no-
prep, 3822 (45.3%) MBP+/ABX-, and 2324 (27.5%) MBP+/ABX+
17 ing disorders, and disseminated cancer in
no-
prep.
18 ne (MBP+/ABX-), and no bowel preparation (
no-
prep) on outcomes, particularly anastomotic leak, surgic
19 ted with lower anastomotic leak rate than
no-
prep [OR = 0.45 (95% CI: 0.32-0.64)].
20 BX-: OR = 0.80, 95% CI: 0.69-0.93] versus
no-
prep.
21 owel preparation compared to those with
poor prep, 90.00% vs. 70.45%, respectively (P < 0.001).
22 d and versatile option for integrated
sample prep or multidimensional analysis, and addresses the gla
23 e test combines DNA sequence specific
sample prep to reduce the co-extraction of qPCR inhibitors with
24 a risk that can be reduced by modifying
skin prep and injection practices.
25 GC step, prior to analyte collection, in
the prep-GC analysis of complex samples.
26 women were positive for trichomonads by
wet prep or culture only in the urine.
27 nt (38 of 51) of women who had a vaginal
wet prep or vaginal culture positive for trichomonads had mi
28 richomonas vaginalis by wet-preparation (
wet-
prep) microscopy and culture and for the presence of T.